Your browser doesn't support javascript.
loading
RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations.
Sidorova, Olga Alexandra; Sayed, Shady; Paszkowski-Rogacz, Maciej; Seifert, Michael; Camgöz, Aylin; Roeder, Ingo; Bornhäuser, Martin; Thiede, Christian; Buchholz, Frank.
Afiliação
  • Sidorova OA; Medical Systems Biology, Faculty of Medicine, Technische Universität Dresden, 01307 Dresden, Germany.
  • Sayed S; Medical Systems Biology, Faculty of Medicine, Technische Universität Dresden, 01307 Dresden, Germany.
  • Paszkowski-Rogacz M; Medical Systems Biology, Faculty of Medicine, Technische Universität Dresden, 01307 Dresden, Germany.
  • Seifert M; Institute for Medical Informatics and Biometry (IMB), Technische Universität Dresden, 01307 Dresden, Germany.
  • Camgöz A; Hopp Children's Cancer Center Heidelberg, 69120 Heidelberg, Germany.
  • Roeder I; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Bornhäuser M; Institute for Medical Informatics and Biometry (IMB), Technische Universität Dresden, 01307 Dresden, Germany.
  • Thiede C; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Buchholz F; National Center for Tumor Diseases (NCT/UCC), 01307 Dresden, Germany.
Cells ; 11(5)2022 03 02.
Article em En | MEDLINE | ID: mdl-35269477

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / DNA Metiltransferase 3A Limite: Adult / Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / DNA Metiltransferase 3A Limite: Adult / Humans Idioma: En Revista: Cells Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha